ChemoCentryx
CCXI
#3601
Rank
NZ$6.55 B
Marketcap
NZ$91.14
Share price
0.00%
Change (1 day)
35.65%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): NZ-$2.81

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is NZ-$3.31. In 2021 the company made an earnings per share (EPS) of NZ-$3.31 a decrease over its 2020 EPS that were of NZ-$1.42.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)NZ-$2.81-15.15%
2021NZ-$3.31133.33%
2020NZ-$1.42-16.49%
2019NZ-$1.7027.63%
2018NZ-$1.33-305.41%
2017NZ$0.65-142.53%
2016NZ-$1.53-19.44%
2015NZ-$1.89-0%
2014NZ-$1.8913.68%
2013NZ-$1.67-16.67%
2012NZ-$2.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.53-689.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.38-171.96%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.19-226.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.12-858.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$15.48-567.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.82-486.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.07-283.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.61-299.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.17-165.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel